Skip to main content
Log in

Characterization of human papillomavirus type 57b: Transforming activity and comparative sequence analysis as probes for biological determinants associated with high-risk oncogenic viruses

  • Published:
Virus Genes Aims and scope Submit manuscript

Abstract

The association of human papillomavirus type 57 (HPV-57) with premalignant and malignant tumors of the nasal cavity was previously reported (Wu et al., Lancet341, 522, 1993). We determined the complete nucleotide sequence of HPV-57b (GenBank 37537), which was molecularly cloned from a benign fungiform papilloma, and compared it with other HPV types and HPV-57a, which was cloned from an inverted papilloma of the maxillary sinus by de Villiers et al. (Virology171, 248. 1989). Comparative and phylogenetic analysis of amino acid sequences of the HPV-57b oncogenes E5, E6, and E7 were performed with HPV-6, 11, 16, and 18. Phylogenetic trees using the Jotun-Hein algorithm indicated a closer relationship of HPV-57b E5 and E7 with corresponding genes of HPV-18. Signature pattern analysis of these two oncogenes was also in agreement with a closer relatedness to HPV-16 and 18 oncogenes, which are associated with a high risk for malignant progression. Compared with 7861 bp of HPV-57a, HPV-57b had 7868 bp as well as differences in the restriction enzyme sites and the open reading frames, including at least five additional ones. To investigate the oncogenic potential of HPV-57b, NIH 3T3 and REF52 cells were cotransfected with two plasmids: pKP54.HPV-57b, which contains the HPV-57b genome, and pMT.neo. 1, which confers resistance to G418. After selection in culture medium containing G418, 58% of the G418r NIH 3T3 colonies and 47% of the G418r REF52 colonies exhibited morphological transformation. These results indicate that the transcriptional regulatory elements and the oncoproteins of HPV-57b are active in vitro to induce cellular transformation, as are other high-risk HPV types.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. BarbosaM.S., VassW.C., LowyD.R., and SchillerJ.T., J Virol65, 292–298, 1991.

    Google Scholar 

  2. BrintonL.A., MuñozN., BoschF.X., ShahK.V., and MeheusA. (eds).The Epidemiology of Cervical Cancer and Human Papillomavirus. International Agency for Research on Cancer, Lyon, France, 1992, pp 3–23.

    Google Scholar 

  3. DalingJ.R. and ShermanK.J., MuñozN., BoschF.X., ShahK.V., and MeheusA. (eds).The Epidemiology of Cervical Cancer and Human Papillomavirus. International Agency for Research on Cancer, Lyon, France, 1992, pp 223–241.

    Google Scholar 

  4. DürstM., GissmannL., IkenbergH., and zurHausenH., Proc Natl Acad Sci USA80, 3812–3815, 1983.

    Google Scholar 

  5. SchiffmanM.H., zurHausenH. (ed).Human Pathogenic Papillomaviruses. Springer-Verlag, Berlin, 1994, pp 131–156.

    Google Scholar 

  6. WuT.-C., TrujilloJ.M., KashimaH.K., and MountsP., Lancet341, 522–524, 1993.

    Google Scholar 

  7. zurHausenH., zurHausenH. (ed)Human Pathogenic Papillomaviruses. Springer-Verlag, Berlin, 1994, pp 131–156.

    Google Scholar 

  8. DanosO., GiriI., ThierryF., and YanivM., J Invest Dermatol83, 7s-11s, 1984.

    Google Scholar 

  9. deVilliersE.-M., zurHausenH. (ed).Human Pathogenic Papillomaviruses. Springer-Verlag, Berlin, 1994, pp 1–12.

    Google Scholar 

  10. deVilliersE.-M., Hirsch-BehnamA., vonKnebel-DoebritzC., NeumanC., and zurHausenH., Virology171, 248–253, 1989.

    Google Scholar 

  11. VanRanstM., KaplanJ.B., and BurkR.D., J Gen Virol73, 2653–2660, 1992.

    Google Scholar 

  12. zurHausenH., RigbyP.W.J. and WilkieN.M. (eds).Viruses and Cancer. Cambridge University Press, Cambridge, 1986, pp 83–90.

    Google Scholar 

  13. DickensP., SrivastavaG., LokeS.L., and, LarkinS., J Pathol165 243–246, 1991.

    Google Scholar 

  14. GissmannL., DiehlV., Schulz-CoulonH.-J., and zurHausenH., J Virol44, 393–400, 1982.

    Google Scholar 

  15. MountsP., ShahK.V., and KashimaH., Proc Natl Acad Sci USA79, 5425–5429, 1982.

    Google Scholar 

  16. OrthG., JablonskaS., Jarzabek-ChorzelskaM., RsezaS., ObalekS., FavreM., and CroissantO., Cancer Res39, 1074–1082, 1979.

    Google Scholar 

  17. YousemS.A., OhoriN.P., and Sonmez-AlpanE., Cancer69, 693–697, 1992.

    Google Scholar 

  18. BrandsmaJ.L. and AbramsonA.L., Cancer Res46, 2185–2188, 1989.

    Google Scholar 

  19. LöningT., IkenbergH., BeckerJ., GissmannL., HoepfnerI., and zurHausenH., J Invest Dermatol84, 417–420, 1985.

    Google Scholar 

  20. JablonskaS., PfisterH. (ed).Papillomaviruses and Human Cancer. CRC Press, Boca Raton FL, 1990, pp 46–71.

    Google Scholar 

  21. RübbenA., KronesR., SchwetschenauB., and Grussendorf-ConenE.-I., Br J Dermatol128 264–270, 1993.

    Google Scholar 

  22. LunguO., CrumC.P., and SilversteinS., J Virol65, 4216–4225, 1991.

    Google Scholar 

  23. PirisiL., YasumotoS., FelleryM., DoningerJ.K., and DiPaoloJ.A., J Virol61, 1061–1066, 1987.

    Google Scholar 

  24. KasherM.S. and RomanA., Virology165, 225–233, 1988.

    Google Scholar 

  25. McGlennenR.C., GhaiJ., OstrowR.S., LaBreshK., SchneiderJ.F., and FarasA.J., Cancer Res52, 5872–5878, 1992.

    Google Scholar 

  26. SangerF. and CoulsonA.R., J Mol Biol94, 441–448, 1975.

    Google Scholar 

  27. WilburW.J. and LipmanD.J., Proc Natl Acad Sci USA80, 726–730, 1983.

    Google Scholar 

  28. HeinJ.J., Methods Enzymol183, 626–645, 1990.

    Google Scholar 

  29. LipmanD.J. and PearsonW.R., Science227, 1435–1441, 1985.

    Google Scholar 

  30. KorberB. and MyersG., AIDS Res Hum Retroviruses8, 1549–1560, 1992.

    Google Scholar 

  31. HalbertC.L. and GallowayD.A., J Virol62, 1071–1075, 1989.

    Google Scholar 

  32. ChinM.T., BrokerT.R., and ChowL.T.,J Virol63, 2967–2976, 1989.

    Google Scholar 

  33. WardP. and MountsP., J Gen Virol19, 1671–1682, 1988.

    Google Scholar 

  34. ChenS.-L. and MountsP., J Virol64, 3226–3243, 1990.

    Google Scholar 

  35. LoganJ., NicholasJ.C., ToppW.C., GirardM., ShenkT., and LevineA.J., Virology115, 419–422, 1981.

    Google Scholar 

  36. Hirsch-BehnamA., DeliusH., and deVilliersE.-M., Virus Res18, 81–98, 1990.

    Google Scholar 

  37. ColeS.T. and DanosO., J Mol Biol193, 599–608, 1987.

    Google Scholar 

  38. FaisstS. and MeyerS., Nucleic Acids Res20, 3–26, 1992.

    Google Scholar 

  39. SettlemanJ., FazeliA., MalickiJ., HorwitzB.H., and DiMaioD., Mol Cel Biol9, 5563–5572, 1989.

    Google Scholar 

  40. RomanczykH., VillaL.L., SchlegelR., HowleyP.M., J Virol65, 2739–2744, 1991.

    Google Scholar 

  41. ScheffnerM., RomanczukH., MüngerK., HuibregsteJ.M., MietzJ.A., HowleyP.M., zurHausenH. (ed).Human Pathogenic Papillomaviruses. Springer-Verlag, Berlin, 1994, pp 131–156.

    Google Scholar 

  42. WatanabeS., KandaT., and YoshikeK., J Virol63, 965–969, 1989.

    Google Scholar 

  43. BakerC.C., SalzmanN.P., and HowleyP.M. (eds).The Papovaviridae, Vol 2. Plenum Press, New York, 1986, pp 1–38.

    Google Scholar 

  44. DartmannK., SchwartzE., GissmannL., and zurHausenH., Virology151, 124–130, 1986.

    Google Scholar 

  45. SchwarzE., DürstM., DemankowskiC., LattermannO., ZechR., WolfspergerE., SuhaiS., and zurHausenH., EMBO J2, 2341–2348, 1983.

    Google Scholar 

  46. ChanS.-Y., DeliusH., HalpernA.L., and BernardH.U., J Virol69, 3074–3083, 1995.

    Google Scholar 

  47. BoschX.F., ManosM.M., MuñozN., ShermanM., JansenA.M., PetoJ., SchiffmanM.H., MorenoV., KurmanR., and ShahK.V., Natl Cancer Inst87, 796–802, 1995.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Phoebe Mounts.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trujillo, J.M., Wu, TC. & Mounts, P. Characterization of human papillomavirus type 57b: Transforming activity and comparative sequence analysis as probes for biological determinants associated with high-risk oncogenic viruses. Virus Genes 12, 165–178 (1996). https://doi.org/10.1007/BF00572955

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00572955

Key words

Navigation